Zheng Quan Shi Bao Wang·2026-01-05 00:11Company Overview - Wanyiyi Medical has submitted a listing application to the Hong Kong Stock Exchange, with Everbright Securities International as the sole sponsor [1] - The company is positioned as a leading AI-driven solution provider in China, focusing on physician talent development, academic exchange, education, and research outcome transformation [1] Market Position - According to Frost & Sullivan, Wanyiyi Medical ranks first in the comprehensive AI solution market for medical academia, education, and research in China based on comparable revenue for 2024 [1] Core Business - The core business includes two types of AI-driven revenue-generating solutions: a full-process solution for medical academic activities provided through the MedEvent platform, and digital solutions for medical learning and education offered via the MedAssistant system [1] - Wanyiyi Medical has also launched the MedEvidence intelligent tool suite, which includes an AI evidence assistant to support physician-led research processes [1] Market Growth - The market for medical academic, education, and research solutions in China is continuously growing, with the comprehensive AI solution market expected to have a compound annual growth rate (CAGR) of 34.8% from 2024 to 2030, reaching a market size of 33.9 billion RMB by 2030 [1]